Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report by Christoph D Spinner et al.
CASE REPORT Open Access
Acute hypophysitis and hypopituitarism in early
syphilitic meningitis in a HIV-infected patient: a
case report
Christoph D Spinner1,5*, Sebastian Noe1, Christiane Schwerdtfeger1,5, Antonia Todorova2,5, Jochen Gaa3,
Roland M Schmid1, Dirk H Busch4,6 and Michael Neuenhahn4,6*
Abstract
Background: Sexually transmitted diseases and most notably syphilis-infections are rising amongst men who have
sex with men. In HIV-co-infected patients, an accelerated clinical course of syphilis neurological involvement is
known.
Case presentation: A 46 year old HIV-positive male patient came in to our emergency department in the late
evening with acute fever, rapidly progressive cephalgia and photophobia. Palmar skin efflorescence was evocative
of an active syphilis infection. A reactive Treponema pallidum particle agglutination (TPPA) assay with positive
Treponema pallidum-specific IgG/IgM immunofluorescence as well as a highly reactive Veneral diseases research
laboratory (VDRL) test confirmed the diagnosis. Liquor pleocytosis, liquor protein elevation and a highly positive
VDRL test in cerebrospinal fluid (CSF) were interpreted in context of the clinical symptoms as neurosyphilitic
manifestations within an early syphilis infection (stage II). Cranial nuclear magnetic resonance scans of the sella
turcica, which were performed due to low thyroidea stimulation hormone (TSH) and thyroxin levels, showed signs
of hypophysitis such as pituitary gland enlargement and inhomogeneous contrast enhancement. Advanced
endocrine laboratory testing revealed hypopituitarism. Fourteen days of intravenous ceftriaxone treatment and
levothyroxine- and hydrocortisone-substitution led to complete disappearance of all clinical symptoms. Two months
later, nuclear magnetic resonance scan showed normal pituitary size and that the syphilis serology had normalized.
Conclusion: We report to the best of our knowledge the first case of a HIV-positive patient with acute hypophysitis
and hypopituarism due to early neurosyphilis infection. Ceftriaxone treatment and levothyroxine- and
hydrocortisone-substitution led to the disappearance of all clinical symptoms. We strongly recommend to exclude
syphilis infection in every clinical situation unclear in HIV-patients, especially when additional risk factors are known.
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Background
Sexually transmitted diseases (STD) and in particular
syphilis infections, caused by the spirochete Treponema
pallidum (subspecies pallidum), are on the rise since the
beginning of this century [1-3]. Men who have sex with
men (MSM) are by far the most affected group in the
western world and Human immunodeficiency virus
(HIV) co-infected MSM have been described to show an
accelerated and more complicated course of syphilis in-
fections with neurological involvement [4-7]. Notably,
cerebrospinal fluid (CSF) and neurological abnormalities
(e.g. meningitis) correlate with low (<=350 cells/μl) CD4
cells counts in HIV seropositive individuals [8,9]. Syph-
ilis infection has also been linked to a specific pituitary
inflammation, named granulomatous hypophysitis, in
analogy to other granulomatous infectious etiologies
[10-13]. There is, however, one case report of pituitary
gland gumma in a HIV-negative congenital syphilis case
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[14]. We here describe to our best knowledge the first
clinical case of acute hypophysitis during an early sy-
philis infection in an adult HIV-positive patient. Though
a rare disorder, physicians should be aware of the
possibility of pituitary inflammation secondary to sy-
philis, since a potential secondary adrenal insufficiency
may develop, which can be lethal if unrecognized and
not treated adequately and immediately.
Case presentation
We here report a case of acute hypophysitis and consecu-
tive hypopituitarism due to an active neurosyphilis infec-
tion in a 46-year old HIV-positive MSM patient. The
patient had rapidly progressive cephalgia for two weeks
and rapid symptom progression (accentuated in the
evening) during the last two days before hospitalization.
On the day of admission, he arrived at our emergency de-
partment with acute fever (39°C) and pronounced photo-
phobia. Beside the combined antiretroviral therapy with
Abacavir, Lamivudin and Efavirenz no other medication
was taken upon first presentation. The HIV load had
been below detection level (< 20 cps/ml) at his last out-
patient visit two months ago and a recent CD4-count
was 507 cells/μl (27%, Ratio CD4/CD8-ratio 0.7). Beside
the known HIV-infection, the STD history was unre-
markable. Six months before the actual admission, a
screening test for syphilis co-infection using the Trepo-
nema pallidum particle agglutination (TPPA) assay had
been negative. Drug abuse was denied and other pre-
existing medical conditions were not known. The HIV
diagnosis in this patient was first made five years ago
due to pneumocystis pneumonia, thrush esophagitis
and buccal mucosa Kaposi’s sarcoma. CDC stage at
first diagnosis was C3 and CD4-nadir was 93 cells/μl.
(8%, CD4/CD8-ratio 0.1). The patient was hospitalized
from the emergency department and on the assumption
of acute meningitis was immediately administered a cal-
culated antimicrobial therapy with intravenous Ceftria-
xone (4 g per day on day 1, followed by 2 g per day),
Ampicillin (6 × 2 g per day) and Aciclovir (3 × 10 mg/kg
body weight per day). An emergency cranial computed
tomography ruled out signs of intracranial pressure.
Lumbar puncture showed mild pleocytosis (10 cells/μl)
and high protein levels (1040 mg/l). The liquor/
serum-albumin-quotient was elevated, indicating blood-
CSF-barrier disturbance (13 × 10-3). Initial laboratory
diagnostics revealed hyponatraemia (130 mmol/l), mild
C-reactive protein elevation (2.1 mg/dl) and abnormal
liver function tests (ALT 68 U/l, AST 85 U/l). Notable
TSH suppression (0,15 μIU/ml) and low free thyroxine
levels (fT4) (0,4 ng/dl) in the routine screening labora-
tory test upon emergency admission led to cranial nu-
clear magnetic resonance (NMR)-imaging of the sella
turcica. This revealed pituitary stalk enlargement with
inhomogeneous contrast enhancement (Figure 1A).
Advanced endocrine laboratory analysis was performed
five days after admission and showed hypopituitarism
with low levels for TSH (0.15 μIU/ml), fT3 (1,6 pg/ml),
fT4 (0,3 ng/ml), luteinising-hormone (LH) (< 0,1 IU/l),
testosterone (< 0,1 IU/l), basal cortisone (0,2 μg/dl) and
insulin-like growth factor (IGF-1) (74 ng/ml). The
patient refused a stereotactic biopsy and histopatho-
logical assessment to rule out malignancy of the pituitary
enlargement.
Subsequent microbiological and viral analysis by nu-
cleic acid amplification ruled out infection of the central
nervous system through Mycobacterium tuberculosis,
Herpes simplex-, Cytomegalo-, Epstein-Barr-, Varicella-
or Enterovirus. Aerobic and anaerobic liquor cultures
were sterile. HIV PCR from peripheral blood showed
A B
Figure 1 NMR scan of enlarged pituitary at diagnosis and after treatment. A. Contrast-enhanced coronal T1-weighted nuclear magnetic
resonance (NMR) scan of the sella turcica showing pituitary and pituitary stalk enlargement with inhomogeneous contrast enhancement. B. Contrast-
enhanced coronal T1-weighted nuclear magnetic resonance (NMR) scan of the sella turcica two months after hypophysitis demonstrates normal
pituitary size.
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low-level viremia (47 copies/ml), but was tested negative
in the cerebrospinal fluid. Upon clinical re-examination
erythematous maculae with distinct edges were detec-
table on the palms and soles. According to the patient
the maculae had been appeared three weeks ago. Con-
sistent with these skin manifestations, a disseminated
early syphilis infection (stage II) was assumed. Syphilis
infection was serologically confirmed by reactive TPPA
(1:10240) and a positive Treponema pallidum-specific
IgG immunofluorescence (IgG-FTA abs) test. The detec-
tion of Treponema pallidum-specific IgM (IgM-FTA abs
and immunoblot) together with high titers in the
Venereal Disease Research Laboratory (VDRL) micro
flocculation test (1:512) in patient serum indicated high
activity of the syphilis infection. Because of the meningi-
tis symptoms and the known accelerated clinical course
of syphilis in HIV-patients specific liquor diagnostics
were performed. Syphilis-specific liquor serology showed
a positive TPPA (1:64) and a highly positive VDRL test
(1:512) in CSF. However, the TPPA-liquor/serum index
(ITpA-index) was normal (1.15) and a retrospectively
performed Treponema pallidum-specific NAT in CSF
was negative. The empirically started Ceftriaxone ther-
apy (2 g per day) led to rapid resolution of the fever
within the first day of treatment and the resolution of
cephalgia and photophobia within the first two days.
Neurosyphilis treatment was continued for a total course
of fourteen days. After exclusion of cerebral Listeria
and HSV infection, the treatment with Aciclovir and
Ampicillin was stopped. Hormone substitution therapy
with levothyroxine (75 μg per day) and hydrocortisone
substitution (50 mg per day) was started for the hypopitu-
itarism and the laboratory values normalized within days.
Under ceftriaxone therapy and levothyroxine and hydro-
cortisone substitution all clinical symptoms completely
cleared. A NMR scan of the sella turcica two months
later showed a normal pituitary size (Figure 1B) and
the patient remained asymptomatic. Hormone substi-
tution was reduced gradually and then completely
stopped. Hormone laboratory results (TSH, fT3, fT4,
cortisone basal level) subsequently remained consis-
tently normal. 6 months after hospitalization, syphilis
serology confirmed a significantly reduced TPPA titer
(1:320), negative Treponema pallidum-specific IgM
immunofluorescence and a normalized VDRL test
(<1:2) in the patient’s serum, indicating successful anti-
biotic treatment.
Conclusion
We report to the best of our knowledge the first case of
a HIV-positive MSM patient with acute hypophysitis
and hypopituarism due to an active syphilis infection.
In the context of the clinical symptoms (meningitis
and disseminated cutaneous exanthema) and a negative
syphilis screening history (only six months before
hospitalization) we interpreted the clinical picture as a
confirmed early secondary syphilis (according to ECDC
definitions) [1]. The high activity of the infection was
illustrated by positive Treponema pallidum-specific
serum IgMs and high VDRL test serum titers (1:512). In
order to treat the presumably syphilitic lesions in the pi-
tuitary gland and the neurological symptoms sufficiently,
we decided to continue intravenous antibiotic treatment
for 14 days according to national treatment guidelines
[4]. CSF abnormalities with blood-CSF-barrier disturb-
ance, CSF pleocytosis, high liquor protein levels (total
protein 1.040,0 mg/l) and in particular a very high CSF
VDRL test reactivity (1:512) were in line with early
neurosyphilis in accordance to CDC guidelines [8]. HIV-
independent Treponema pallidum invasion of the CSF
in patients with early syphilis is known in approximately
one-third of all cases [10]. Interestingly the number of
neurosyphilis cases in early syphilis-infected patients in-
creased in the HIV era rapidly [2,3,15]. This might be
due to impaired syphilis infection control after CNS in-
volvement due to compromised host immune activity as
a result of HIV-infection [5-7,10]. Especially HIV-
patients with a CD4-count < 350 cells/μl seem to be
under a higher risk of developing cerebrospinal fluid
(CSF) and neurological abnormalities (e.g. meningitis)
[9]. However, in this case, symptomatic bacterial replica-
tion in the central nervous system could not be formally
proven according to national diagnostic criteria, because
the ITpA index was not elevated [4,11-13]. A retro-
spectively performed Treponema pallidum-specific
NAT from CSF was also negative, but a recent meta-
analysis reported low sensitivity (47%) in retrospective
CSF PCR samples from patients with neurosyphilis
[14,16]. In any case, the complete neurological, endo-
crinological and serological recovery after ceftriaxone
treatment count as the strongest argument for Trepo-
nema pallidum-caused hypophysitis and consecutive
hypopituitarism.
We strongly recommend to rule out syphilis in every
uncertain clinical situation in HIV-patients, especially
when additional risk factors (MSM or others) are
known. Syphilis-specific CSF diagnostic should be
performed whenever any additional signs of neurosy-
philis occur. A CSF VDRL test could be helpful to
diagnose neurosyphilis when other signs of neurosyphilis
are missing.
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